Loading...
XSHE300685
Market cap1.16bUSD
Jan 14, Last price  
21.73CNY
1D
2.79%
1Q
-2.07%
IPO
380.91%
Name

Amoy Diagnostics Co Ltd

Chart & Performance

D1W1MN
XSHE:300685 chart
P/E
32.58
P/S
8.16
EPS
0.67
Div Yield, %
0.65%
Shrs. gr., 5y
0.37%
Rev. gr., 5y
18.90%
Revenues
1.04b
+23.91%
38,146,80374,377,840106,810,759176,877,645252,987,005330,371,305439,031,481578,355,544728,390,555917,033,391842,180,4271,043,506,694
Net income
261m
-0.86%
7,972,53322,049,69919,138,94321,085,15767,033,94894,065,765126,737,914135,474,211180,326,353239,573,622263,743,023261,484,433
CFO
299m
+100.43%
-210,0008,556,60015,690,81319,095,86732,184,85191,890,08793,448,159151,524,817220,694,485168,161,324149,036,792298,715,870
Dividend
May 30, 20240.15 CNY/sh
Earnings
May 13, 2025

Profile

Amoy Diagnostics Co., Ltd., a diagnostic company, focuses on molecular diagnostics for oncology precision medicine in China and internationally. The company offers NGS, real-time PCR, FISH, and extraction assays. Amoy Diagnostics Co., Ltd. was founded in 2008 and is based in Xiamen, China.
URL
https://www.amoydx.com/
IPO date
Aug 02, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,043,507
23.91%
842,180
-8.16%
Cost of revenue
731,991
668,656
Unusual Expense (Income)
NOPBT
311,515
173,524
NOPBT Margin
29.85%
20.60%
Operating Taxes
33,373
21,791
Tax Rate
10.71%
12.56%
NOPAT
278,143
151,733
Net income
261,484
-0.86%
263,743
10.09%
Dividends
(55,190)
(51,469)
Dividend yield
0.63%
0.49%
Proceeds from repurchase of equity
(12,035)
(1)
BB yield
0.14%
0.00%
Debt
Debt current
5,005
5,338
Long-term debt
48,734
49,966
Deferred revenue
10,517
10,264
Other long-term liabilities
Net debt
(1,023,121)
(698,678)
Cash flow
Cash from operating activities
298,716
149,037
CAPEX
(44,865)
Cash from investing activities
(331,994)
Cash from financing activities
(18,044)
FCF
290,740
53,580
Balance
Cash
1,021,910
753,982
Long term investments
54,949
Excess cash
1,024,684
711,873
Stockholders' equity
1,408,111
1,229,351
Invested Capital
740,726
842,983
ROIC
35.13%
19.71%
ROCE
17.65%
11.16%
EV
Common stock shares outstanding
396,189
393,646
Price
21.98
-16.90%
26.45
-36.95%
Market cap
8,708,224
-16.36%
10,411,945
-37.84%
EV
7,685,103
9,713,267
EBITDA
368,061
225,796
EV/EBITDA
20.88
43.02
Interest
1,569
993
Interest/NOPBT
0.50%
0.57%